Greenwich Wealth Management’s Inovio Pharmaceuticals INO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$43K	Buy	24,899 +900	+4%	+$1.48K	﹤0.01%	303
2025 Q4	$42K	Buy	23,999 +3,600	+18%	+$7.93K	﹤0.01%	284
2025 Q3	$48K	Buy	+20,399	New	+$39.1K	﹤0.01%	274
2024 Q1	–	Sell	-2,548	Closed	-$16K	–	248
2023 Q4	$16K	Sell	2,548 -394	-13%	-$1.95K	﹤0.01%	231
2023 Q3	$14K	Buy	2,942 +150	+5%	+$829	﹤0.01%	226
2023 Q2	$15K	Buy	2,792 +1,042	+60%	+$8.4K	﹤0.01%	235
2023 Q1	$17K	Buy	1,750 +192	+12%	+$3.27K	﹤0.01%	234
2022 Q4	$29K	Sell	1,558 -1,034	-40%	-$23.4K	﹤0.01%	234
2022 Q3	$54K	Buy	2,592 +38	+1%	+$973	0.01%	229
2022 Q2	$53K	Hold	2,554	–	–	0.01%	228
2022 Q1	$110K	Buy	2,554 +150	+6%	+$6.76K	0.01%	231
2021 Q4	$144K	Sell	2,404 -509	-17%	-$40.8K	0.01%	238
2021 Q3	$250K	Buy	2,913 +759	+35%	+$76.2K	0.02%	207
2021 Q2	$240K	Buy	2,154 +208	+11%	+$20K	0.02%	195
2021 Q1	$217K	Buy	1,946 +942	+94%	+$124K	0.02%	185
2020 Q4	$107K	Buy	+1,004	New	+$134K	0.01%	191
2019 Q4	–	Sell	-892	Closed	-$22K	–	192
2019 Q3	$22K	Buy	+892	New	+$27.1K	﹤0.01%	179